Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of JKN2301 dry suspension in children with uncomplicated influenza
CTR20254260Phase 3Active
- Sponsor
- Joincare Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil, oseltamivir in influenza, Influenza A infection, influenza B, sponsored by Joincare Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
baloxavir marboxiloseltamivir
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20254260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254260.